Patent · US Expired

Method of preventing and treating bacterial infection of sutures and prosthetic devices, and promoting ingress of leukocytes into tumor foci

US5843436A · kind A · utility

10Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 22, 1996
Grant dateDec 1, 1998
Priority date
Expiry dateApr 22, 2016

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/1709
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An agent capable of inhibiting signalling mediated by a .beta..sub.1 integrin cell surface receptor of leukocyte cells will treat a bacterial infection associated with a surface of a foreign body over and around which fibrin has been deposited, or a malignant tumor over and around which tenascin has been deposited. In addition, coating a foreign body with a fibrinolytic agent will prevent chronic bacterial infection associated with the surface of the foreign body. Furthermore, an agent capable of stimulating signalling mediated by a .beta..sub.1 integrin cell surface receptor of leukocyte cells will treat chronic inflammation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.